~~<i id='B98775009B'><strike id='B98775009B'><tt id='B98775009B'><pre id='B98775009B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：knowledge 2025-09-30 00:01:02 - browse：128

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： 5 important ways Henrietta Lacks changed medical science

hotspot

explore

Wikipedia

knowledge

leisure time

Anaphylaxisisalife-threateningmedicalemergencyandhastobetreatedwithepinephrine,sometimesdeliveredthr

WSS

STAT Readout Newsletter: Today's biggest biotech updates

Scientists inch closer to single

Eli Lilly expects to double planned employment in Boston center

New safety details link Apellis eye drug to rare cases of blindness

The high personal cost of affirmative action for Black doctors

STAT Summit: Biotech founders on deal

hotspot

Wikipedia

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

The high personal cost of affirmative action for Black doctors

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

NIH launches clinical trials and new research office for long Covid

BioMarin wins approval for gene therapy to treat hemophilia A

Eli Lilly expects to double planned employment in Boston center

Novavax promises a turnaround & Lilly roils the obesity market

Trump indictment: Who are the 'co

ChatGPT in medicine: STAT answers readers' burning questions

Mitch McConnell episode has important public health takeaway

explore

Hospital price transparency does save money, advocate argues

Pharmacists can make shortage drugs, but at what cost?

NIH confirmation hearing shows politicization of research

How climate

What the US credit downgrade means for the economy, your finances

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Wikipedia

Wikipedia

knowledge

leisure time